PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mayo Clinic IDs genes that predict whether trastuzumab will work for breast cancer patients

2012-12-08
(Press-News.org) SAN ANTONIO, Texas -- Adding the drug trastuzumab to chemotherapy prevents cancer recurrence and improves survival in a large number of women with early stage HER2-positive breast cancer. But trastuzumab does not stop tumors from returning in about 25 percent of patients — and oncologists haven't been able to identify these women before treatment. This situation may soon change, according to a Mayo Clinic study being presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium.

VIDEO ALERT: Video of Dr. Perez is available on the Mayo Clinic News Network.

A team of U.S. researchers, led by oncologists at Mayo Clinic's campus in Florida, have discovered 27 genes that are significantly associated with a good outcome with concurrent use of trastuzumab and chemotherapy, as well as five other genes linked to a poor outcome using the same treatment regimen.

Results of their study — believed to be the first to use gene expression profiling to predict outcome to trastuzumab as part of adjuvant breast cancer therapy — offer a number of future potential benefits, says Edith Perez, M.D., deputy director at large of the Mayo Clinic Comprehensive Cancer Center and director of the Breast Cancer Translational Genomics Program at Mayo Clinic.

"These findings also are getting us closer to unraveling the biological factors that are relevant to patient outcome, which will help us improve clinical care," Dr. Perez says.

For example, the discovery may help scientists devise a genetic test that can help oncologists select the best treatment for their HER2-positive patients, she says.

Further analysis will illuminate the inner biological workings of individual HER2-positive tumors, which could provide clues for novel treatments, Dr. Perez adds. The researchers have already found that the genes linked to outcome can be grouped into different categories that affect tumor functioning, such as cell cycle, cell death, cell receptor signaling, and gene transcription.

Dr. Perez and her team plan to validate their findings through collaborations with researchers in the United States and Europe who have led other trastuzumab clinical studies.

"We are on our way to developing a predictive test that can define the right treatment for individual patients, and that is very exciting," she says.

The study was funded by grants from the National Cancer Institute and Mayo Clinic, with further support from the Breast Cancer Research Foundation and the 26.2 with Donna Foundation. The N9831 clinical trial was conducted by the North Central Cancer Treatment Group, now part of the Alliance for Clinical Trials in Oncology. Dr. Perez is a group vice chair for the Alliance.

### The study's co-authors include researchers from Mayo Clinic's campuses in Florida, Minnesota and Arizona, Indiana University, Dana-Farber Cancer Institute, the University of Washington, and Ventana Medical Systems-Roche in Tucson, Ariz.

The Alliance for Clinical Trials in Oncology is a national clinical trials network sponsored by the National Cancer Institute that consists of a network of nearly 10,000 cancer specialists at hospitals, medical centers, and community clinics across the country and Canada. The Alliance is dedicated to developing and conducting clinical trials with promising new cancer therapies, and utilizes the best science to develop optimal treatment and prevention strategies for cancer, as well as researching methods to alleviate side effects of cancer and cancer treatments. To learn more about the Alliance, visit the Alliance website.

About Mayo Clinic Cancer Center As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 507-538-7623.

About Mayo Clinic Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit MayoClinic.com or MayoClinic.org/news.

Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.

Contacts:

At SABCS (Dec. 4-8, 2012) Joe Dangor
507-284-5005 (days)
507-284-2511 (evenings)
Email: newsbureau@mayo.edu Paul Scotti (all other dates/times)
904-953-2299 (days)
904-953-2000 (evenings)
Email: scotti.paul@mayo.edu END


ELSE PRESS RELEASES FROM THIS DATE:

New small molecule inhibitor could be a safe and first-line treatment for metastatic breast cancer

2012-12-08
SAN ANTONIO, TX (December 7, 2012)—Previous research has shown that a family of genes, proteins and enzymes called the uPA system (for urokinase plasminogen activator) plays an active role in different facets of cancer's biology, including tumor cell invasion, the spread of metastases, and the growth of a primary tumor. Mesupron® is a new small molecule inhibitor, taken as a pill, that inhibits the uPA system. The results from a recent phase II clinical study suggest that the drug could be a safe and first-line treatment that extends progression-free survival for metastatic ...

Green scientists propose safety testing system for development of new chemicals

2012-12-08
PITTSBURGH—A group of scientists from North America and Europe, including Carnegie Mellon University's Terry Collins, has developed a five-tiered testing system that manufacturers can use to ensure that the chemicals and consumer products they produce are free of harmful endocrine disrupting chemicals like BPA or DDT. Their study, "Designing Endocrine Disruption Out of the Next Generation of Chemicals," will be published in the January 2013 issue of the Royal Society of Chemistry journal Green Chemistry, and is currently available online. Endocrine disrupting chemicals, ...

Greenland ice sheet carries evidence of increased atmospheric acidity

Greenland ice sheet carries evidence of increased atmospheric acidity
2012-12-08
Research has shown a decrease in levels of the isotope nitrogen-15 in core samples from Greenland ice starting around the time of the Industrial Revolution. The decrease has been attributed to a corresponding increase in nitrates associated with the burning of fossil fuels. However, new University of Washington research suggests that the decline in nitrogen-15 is more directly related to increased acidity in the atmosphere. The increased acidity can be traced to sulfur dioxide, which in the atmosphere is transformed to sulfuric acid, said Lei Geng, a UW research ...

NASA casts infrared eye on Southern Indian Ocean's Tropical Cyclone Claudia

NASA casts infrared eye on Southern Indian Oceans Tropical Cyclone Claudia
2012-12-08
The third tropical cyclone in the Southern Indian Ocean has been renamed Tropical Cyclone Claudia as NASA's Aqua satellite passed overhead.The AIRS instrument on Aqua captured infrared imagery of Claudia over two days that showed the western quadrant is most powerful part of the cyclone. Aqua flew over Tropical Cyclone Claudia on Dec. 6 at 1959 UTC (2:59 p.m. EST/U.S.) and Dec. 7 at 0811 UTC (3:11 a.m. EST/U.S.). The Atmospheric Infrared Sounder (AIRS) instrument analyzes storms in infrared light, and revealed the temperatures of clouds and sea surface around the storm. ...

NASA infrared data shows Typhoon Bopha re-strengthened in South China Sea

NASA infrared data shows Typhoon Bopha re-strengthened in South China Sea
2012-12-08
The deadly typhoon that caused almost 300 deaths in the southern Philippines is making a loop in the South China Sea, and infrared NASA satellite data indicated that Bopha re-intensified. NASA's Aqua satellite passed over Bopha on Dec. 6 at 1811 UTC (1:11 p.m. EST, U.S.) and the Atmospheric Infrared Sounder (AIRS) instrument aboard captured an infrared look at the storm. The infrared data revealed where the coldest, highest cloud tops were. The coldest cloud tops indicate the strongest storms with the heaviest rain, and AIRS data revealed they surrounded the center of ...

2013 will be a good year, NJIT biz professor forecasts at Chicago Fed Board

2012-12-08
Economic growth will rise to 3 percent in 2013 and 2014, while unemployment will drop to 7.3 percent by December of 2013, NJIT Leir Research Professor William V. Rapp, PhD, http://www.njit.edu/news/experts/rapp.php, told economists and others last week at the annual outlook symposium, http://www.chicagofed.org/webpages/events/eos_series.cfm, sponsored by the Chicago Federal Reserve Bank. The first Henry J. Leir Professor of International Trade and Business in the NJIT School of Management, Rapp was invited to participate in the annual event which draws the nation's ...

Another muscular dystrophy mystery solved; MU scientists inch closer to a therapy for patients

Another muscular dystrophy mystery solved; MU scientists inch closer to a therapy for patients
2012-12-08
COLUMBIA, Mo. -- Approximately 250,000 people in the United States suffer from muscular dystrophy, which occurs when damaged muscle tissue is replaced with fibrous, bony or fatty tissue and loses function. Three years ago, University of Missouri scientists found a molecular compound that is vital to curing the disease, but they didn't know how to make the compound bind to the muscle cells. In a new study, published in the Proceedings of the National Academies of Science, MU School of Medicine scientists Yi Lai and Dongsheng Duan have discovered the missing pieces to this ...

Long-distance solute transport in trees improved by intercellular pathways in living woody tissues

Long-distance solute transport in trees improved by intercellular pathways in living woody tissues
2012-12-08
As large organisms, trees face some remarkable challenges, particularly regarding long-distance transport and communication. In addition to moving water and nutrients from their roots to their leaves, they must also integrate cell-to-cell communication over large areas. Furthermore, in order to function as a single, cohesive organism they must be able to effectively and efficiently send vital substances—such as DNA regulating signals—long distances along a network of cells, sieve-tubes, and vessels. But how effective is this cell-to-cell communication and how far can ...

Massive crevasses and bendable ice affect stability of Antarctic ice shelf, CU research team finds

Massive crevasses and bendable ice affect stability of Antarctic ice shelf, CU research team finds
2012-12-08
Gaping crevasses that penetrate upward from the bottom of the largest remaining ice shelf on the Antarctic Peninsula make it more susceptible to collapse, according to University of Colorado Boulder researchers who spent the last four Southern Hemisphere summers studying the massive floating sheet of ice that covers an area twice the size of Massachusetts. But the scientists also found that ribbons running through the Larsen C Ice Shelf – made up of a mixture of ice types that, together, are more prone to bending than breaking – make the shelf more resilient than it otherwise ...

Wildfires light up western Australia

Wildfires light up western Australia
2012-12-08
Careful observers of the new "Black Marble" images of Earth at night released this week by NASA and the National Oceanic and Atmospheric Administration have noticed bright areas in the western part of Australia that are largely uninhabited. Why is this area so lit up, many have asked? Away from the cities, much of the night light observed by the NASA-NOAA Suomi NPP satellite in these images comes from wildfires. In the bright areas of western Australia, there are no nearby cities or industrial sites but, scientists have confirmed, there were fires in the area when Suomi ...

LAST 30 PRESS RELEASES:

Singles differ in personality traits and life satisfaction compared to partnered people

President Biden signs bipartisan HEARTS Act into law

Advanced DNA storage: Cheng Zhang and Long Qian’s team introduce epi-bit method in Nature

New hope for male infertility: PKU researchers discover key mechanism in Klinefelter syndrome

Room-temperature non-volatile optical manipulation of polar order in a charge density wave

Coupled decline in ocean pH and carbonate saturation during the Palaeocene–Eocene Thermal Maximum

Unlocking the Future of Superconductors in non-van-der Waals 2D Polymers

Starlight to sight: Breakthrough in short-wave infrared detection

Land use changes and China’s carbon sequestration potential

PKU scientists reveals phenological divergence between plants and animals under climate change

Aerobic exercise and weight loss in adults

Persistent short sleep duration from pregnancy to 2 to 7 years after delivery and metabolic health

Kidney function decline after COVID-19 infection

Investigation uncovers poor quality of dental coverage under Medicare Advantage

Cooking sulfur-containing vegetables can promote the formation of trans-fatty acids

How do monkeys recognize snakes so fast?

Revolutionizing stent surgery for cardiovascular diseases with laser patterning technology

Fish-friendly dentistry: New method makes oral research non-lethal

Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)

A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets

New scan method unveils lung function secrets

Searching for hidden medieval stories from the island of the Sagas

Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model

Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label

Twelve questions to ask your doctor for better brain health in the new year

Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes

Study identifies genetic cause for yellow nail syndrome

New drug to prevent migraine may start working right away

Good news for people with MS: COVID-19 infection not tied to worsening symptoms

Department of Energy announces $179 million for Microelectronics Science Research Centers

[Press-News.org] Mayo Clinic IDs genes that predict whether trastuzumab will work for breast cancer patients